SCHEMBL4729080

SCHEMBL4729080

CC(=O)CC(Cl)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 2/20 0.50
MAPT P10636 1/20 0.50
HPGD P15428 1/20 0.46
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
KMT2A Q03164 2/20 0.42
ALB P02768 1/20 0.42
CYP2C9 P11712 1/20 0.42
PCSK7 Q16549 1/20 0.42
HSD17B10 Q99714 1/20 0.42
VKORC1 Q9BQB6 1/20 0.42
MEN1 O00255 1/20 0.42
CYP2D6 P10635 1/20 0.41
SRC P12931 1/20 0.41
GABBR2 O75899 1/20 0.41
GABBR1 Q9UBS5 1/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 3/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11158835 0.85 MTNR1A (0.42) ALDH1A1KDM4EMAPTHPGDMTNR1A
SCHEMBL3355942 0.83 CYP2D6 (0.44) ALDH1A1KDM4EMAPTHPGDCYP2D6
SCHEMBL1131704 0.83 GABBR2 (0.53) MAPTCYP2D6SRCGABBR2GABBR1
Acetamide SCHEMBL27959240 0.82 CYP2C19 (0.47) ALDH1A1KDM4EMAPTHPGDMTNR1A
SCHEMBL6935978 0.82 STAT3 (0.46) ALDH1A1HPGDKMT2AMEN1LMNA
SCHEMBL8660435 0.82 POLB (0.42) ALDH1A1KDM4EMAPTHPGDKMT2A
SCHEMBL4623899 0.82 ESR1 (0.46) ALDH1A1KDM4EMAPTKMT2ACYP2C9
SCHEMBL5321358 0.82 BRD4 (0.50) KMT2ACYP2C9HSD17B10MEN1CYP2D6
SCHEMBL9491712 0.81 LMNA (0.43) ALDH1A1KDM4EMAPTHPGDCYP2D6
SCHEMBL109205 0.80 LMNA (0.53) ALDH1A1KDM4EMAPTHPGDMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008011074-A2 HISTONE DEACETYLASE INHIBITORS ERRANT GENE THERAPEUTICS, LLC (US) 2008-01-24 WO disclosed
EP-1511729-A4 HISTONE DEACETYLASE INHIBITORS BASED ON ALPHACHALCOGENMETHYLCARBONYL COMPOUNDS ERRANT GENE THERAPEUTICS LLC (US) 2006-09-06 EP disclosed
EP-1511729-A1 HISTONE DEACETYLASE INHIBITORS BASED ON ALPHACHALCOGENMETHYLCARBONYL COMPOUNDS Errant Gene Therapeutics, LLC (US) 2005-03-09 EP disclosed
WO-2003099789-A1 HISTONE DEACETYLASE INHIBITORS BASED ON ALPHACHALCOGENMETHYLCARBONYL COMPOUNDS ERRANT GENE THERAPEUTICS, LLC. (US) 2003-12-04 WO disclosed
WO-2001073438-A1 RICIN INHIBITORS AND METHODS FOR USE THEREOF RESEARCH DEVELOPMENT FOUNDATION (US) 2001-10-04 WO disclosed
EP-0865426-A1 AMINO ACID DERIVATIVES, MEDICAMENTS CONTAINING SAID COMPOUNDS AND METHODS OF PRODUCING SAID COMPOUNDS Dr. Karl Thomae GmbH (DE) 1998-09-23 EP disclosed
WO-1997019914-A1 AMINO ACID DERIVATIVES, MEDICAMENTS CONTAINING SAID COMPOUNDS AND METHODS OF PRODUCING SAID COMPOUNDS DR. KARL THOMAE GMBH (DE) 1997-06-05 WO disclosed
EP-0571471-A1 5-HETEROYL INDOLE DERIVATIVES. PFIZER (US) 1993-12-01 EP disclosed